Victoza: An Ozempic-like Generic GLP-1 Medicine Now Accessible Gambar
The first-ever generic GLP-1 medication to be made available in the US, Victoza (liraglutide), was recently introduced by Teva Pharmaceuticals. Glucagon-like peptide-1 receptor agonists, or GLP-1s or GLP-1 RAs, are a family of incretin medications used to treat obesity and diabetes by acting as the body's natural hormone replacements. In this class, other popular medications include tirzepatide (marketed as Mounjaro and Zepbound) and semaglutide (marketed as Ozempic and Wegovy). The latter stimulates both GLP-1 and GIP receptors, earning it the moniker "dual agonistTrusted Source." Some patients have lost up to 25% of their body weight thanks to the medications, which have shown to be incredibly beneficial, especially for weight lossTrusted Source. Numerous other positive effects, such as decreasing A1C and enhancing cardiovascular outcomes, have also been demonstrated. But occasionally, the medications' popularity has gotten out of hand, creating problems with th